Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 600 clinical trials
None
Multicentric Comparative Study Between a Conventional and an Intensive Follow up Strategy After Treatment of a Head and Neck Squamous Cell Carcinoma

imaging including PET-CT for patients N2) performed 2 to 4 months after the end of treatment. The randomization ratio is 1:1.

squamous cell carcinoma
cancer
  • 0 views
  • 23 Jan, 2021
None
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors

PET/CT) can further detect tumors. Eligibility People ages 12 and older with VHL that causes tumors and cysts to grow in the pancreas Design

pet/ct scan
ct scan
dotatate
cyst
genetic testing
  • 0 views
  • 05 Dec, 2021
  • 1 location
None
Diagnosis of Pheochromocytoma

(positron emission tomography) PET/CT. These scans may be done before and/or after surgical removal of pheochromocytoma. Research PET scanning is done using an injection of radioactive compounds

ct scan
adrenaline
metastatic disease
blood test
iobenguane
  • 20 views
  • 05 Sep, 2021
  • 2 locations
None
Screening for Occult Malignancy in Patients With Unprovoked Venous Thromboembolism

occult cancer especially based on FDG PET/CT, and suggests that the best target population for cancer screening would be patients with unprovoked VTE older than 50 years of age (6.7% in patients aged 50

cancer
  • 12 views
  • 18 Oct, 2021
  • 21 locations
None
18F-DOPA II - PET Imaging Optimization

A single centre non-randomized, non-blinded phase III prospective cohort study of 18F-DOPA PET/CT imaging in specific patient populations: Pediatric patients (less than 18 years

  • 0 views
  • 29 Apr, 2021
  • 1 location
None
PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer

. Positron emission tomography / computer tomography (PET/CT) is a nuclear medicine diagnostic imaging procedure based on the measurement of positron emission from radiolabeled tracer molecules

metastatic prostate cancer
pet/ct scan
prostate cancer metastatic
bone scan
metastasis
  • 0 views
  • 16 Aug, 2021
  • 1 location
None
PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases

in number (oligorecurrence) using choline or PSMA PET-CT. As there are no specific treatment recommendations for these type of patients, different treatment approaches are currently used, mostly

adenocarcinoma
stereotactic body radiotherapy
pet/ct scan
cancer
adenocarcinoma of prostate
  • 216 views
  • 26 Jan, 2021
  • 40 locations
None
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma the EQUATE Trial

This phase III trial compares the combination of four drugs (daratumumab, bortezomib, lenalidomide and dexamethasone) to the use of a three drug combination (daratumumab, lenalidomide and dexamethasone). Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as lenalidomide, …

measurable disease
cancer
bortezomib
bone marrow procedure
chemotherapy drugs
  • 0 views
  • 05 Dec, 2021
  • 377 locations
None
Testing the Addition of Ixazomib to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma OPTIMUM Trial

This phase III trial studies how well lenalidomide in combination with ixazomib works compared to lenalidomide alone in treating patients with evidence of residual multiple myeloma after stem cell transplantation. Lenalidomide may help shrink or slow the growth of multiple myeloma. Ixazomib may stop the growth of cancer cells by …

progressive disease
lenalidomide
chemotherapy regimen
neutrophil count
platelet count
  • 0 views
  • 05 Dec, 2021
  • 144 locations
None
Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer

This phase III trials studies whether maintenance immunotherapy (nivolumab) following definitive treatment with radiation and chemotherapy (cisplatin) result in significant improvement in overall survival (time being alive) and progression-free survival (time being alive without cancer) for patients with intermediate risk human papillomavirus (HPV) positive oropharynx cancer (throat cancer) that has …

  • 163 views
  • 05 Dec, 2021
  • 547 locations